Sale

Traveller’s Diarrhoea Treatment Market

Global Traveller’s Diarrhoea Treatment Market Share, Size, Analysis: By Drug Type: Oral Rehydration Therapy (ORS), Antidiarrhoeal Agents, Vaccines/Prophylactics, Others; By Pathogen: Bacteria, Viruses, Protozoa, Others; By Age: Adult, Children; By Route of Administration; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Traveller’s Diarrhoea Treatment Market Outlook

The global traveller’s diarrhoea treatment market size is expected to grow at a CAGR of 6% during the forecast period of 2024-2032, driven by the rapidly growing tourism industry across the globe.

 

Global Traveller’s Diarrhoea Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Traveller’s Diarrhoea Treatment Market: Introduction and Insights

Traveller’s diarrhoea treatment is referred to a treatment for a condition in which intestine and stomach are infected, majorly caused by the unsanitary conditions while handling edibles. Traveller’s diarrhoea is characterised by frequent lose stools and abdominal cramps triggered by the consumption of contaminated food and unfiltered water.

 

The growth of traveller’s diarrhoea treatment market is being driven by the huge number of market players that offer significant competition. The market is stimulated by the growing emphasis on the adoption of the latest technological advancement by manufacturers of drugs, along with offering specialized distribution channels for drugs for the treatment of traveller’s diarrhoea.

 

Moreover, the latest product development to formulate specialized drugs and vaccines for the treatment of traveller’s diarrhoea with preventive effect, is shifting the market scenario for the treatment of traveller’s diarrhoea. In addition, the launch of new vaccine produced by the manufacturer is predicted to boost competition among the manufacturers of traveller’s diarrhoea treatment industry, further encouraging market growth.

 

Traveller’s Diarrhoea Treatment Market Segmentations

The market can be categorized into segments like drug type, pathogen, age, route of administration, distribution channel, and region.

 

Global Traveller’s Diarrhoea Treatment Market By Age

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Breakup by Drug Type

  • Oral Rehydration Therapy (ORS)
  • Antidiarrhoeal Agents
    • Antibiotics
    • Azithromycin
    • Ciprofloxacin
    • Quinolones
    • Rifaximin
    • Others
  • Vaccine/Prophylactics
  • Others

 

Market Breakup by Pathogen

  • Bacteria
  • Viruses
  • Protozoa
  • Others

 

Market Breakup by Age

  • Adult
  • Children

 

Market Breakup by Route of Administration

  • Oral
  • Parenteral

 

Market by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

 

Market Breakup by Region

  • North America
    • United States of America
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others

 

Global Traveller’s Diarrhoea Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Booming Tourism Business in the Developing Countries to Aid the Growth of Traveller’s Diarrhoea Treatment Market

The market growth is being driven by the rising number of regular flyers and booming tourism business in developing countries. The traveller’s diarrhoea treatment is crucial to the traveller’s itinerary and contributes significantly to the patient’s wellbeing while travelling abroad. In addition, the growing awareness among the masses about the traveller’s diarrhoea treatment is expected to provide impetus to the market growth of traveller’s diarrhoea treatment. The ease and convenience in acquiring the treatment drugs for traveller’s diarrhoea, along with the availability of over-the-counter medications is expected to provide lucrative opportunities for the growth of traveller’s diarrhoea treatment market.

 

Key Players in the Global Traveller’s Diarrhoea Treatment Market

The report gives a detailed analysis of the following key players in the global traveller’s diarrhoea treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

 

  • Bausch Health Companies Inc.
  • COSMO Pharmaceuticals
  • Immuron Ltd.
  • Sanofi SA
  • Bayer AG
  • Merck & Co., Inc
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Basilea Pharmaceutica Ltd
  • Eli Lilly and Company

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Type
  • Pathogen
  • Age
  • Route of Administration
  • Distribution Channel
  • Region
Breakup by Drug Type
  • Oral Rehydration Therapy (ORS)
  • Antidiarrhoeal Agents
  • Vaccine/Prophylactics
  • Others
Breakup by Pathogen
  • Bacteria
  • Viruses
  • Protozoa
  • Others
Breakup by Age
  • Adult
  • Children
Breakup by Route of Administration
  • Oral
  • Parenteral
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Bausch Health Companies Inc.
  • COSMO Pharmaceuticals
  • Immuron Ltd.
  • Sanofi SA
  • Bayer AG
  • Merck & Co., Inc
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Basilea Pharmaceutica Ltd
  • Eli Lilly and Company

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Traveller’s Diarrhoea Overview

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Traveller’s Diarrhoea Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Traveller’s Diarrhoea Epidemiology (2016-2031)
    5.3    Europe Traveller’s Diarrhoea Epidemiology (2016-2031)
    5.4    Asia-Pacific Traveller’s Diarrhoea Epidemiology (2016-2031)
    5.5    Latin America Traveller’s Diarrhoea Epidemiology (2016-2031)
    5.6    Middle East & Africa Traveller’s Diarrhoea Epidemiology (2016-2031)
6    Global Traveller’s Diarrhoea Treatment Market Overview 
    6.1    Global Traveller’s Diarrhoea Treatment Market Historical Value (2017-2023) 
    6.2    Global Traveller’s Diarrhoea Treatment Market Forecast Value (2024-2032)
7    Global Traveller’s Diarrhoea Treatment Market Landscape
    7.1    Traveller’s Diarrhoea Treatment: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Traveller’s Diarrhoea Treatment: Product Landscape
        7.2.1    Analysis by Drug Type
        7.2.2    Analysis by Pathogen
        7.2.3    Analysis by Age
        7.2.4    Analysis by Route of Administration
        7.2.5    Analysis by Distribution Channel 
8    Traveller’s Diarrhoea Treatment Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Traveller’s Diarrhoea Treatment Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Traveller’s Diarrhoea Treatment Market Segmentation
    11.1    Global Traveller’s Diarrhoea Treatment Market by Drug Type
        11.1.1    Market Overview
        11.1.2    Oral Rehydration Therapy (ORS)
        11.1.3    Antidiarrhoeal Agents
            11.1.3.1    Antibiotics
            11.1.3.2    Azithromycin
            11.1.3.3    Ciprofloxacin
            11.1.3.4    Quinolones
            11.1.3.5    Rifaximin
            11.1.3.6    Others
        11.1.4    Vaccine/Prophylactics
        11.1.5    Others
    11.2    Global Traveller’s Diarrhoea Treatment Market by Pathogen 
        11.2.1    Market Overview
        11.2.2    Bacteria 
        11.2.3    Viruses
        11.2.4    Protozoa
        11.2.5    Others
    11.3    Global Traveller’s Diarrhoea Treatment Market by Age
        11.3.1    Market Overview
        11.3.2    Adult
        11.3.3    Children
    11.4    Global Traveller’s Diarrhoea Treatment Market by Route of Administration
        11.4.1    Market Overview
        11.4.2    Oral
        11.4.3    Parenteral
    11.5    Global Traveller’s Diarrhoea Treatment Market by Distribution Channel
        11.5.1    Market Overview
        11.5.2    Hospital Pharmacies
        11.5.3    Retail Pharmacies
        11.5.4    Online Pharmacies
        11.5.5    Others
    11.6    Global Traveller’s Diarrhoea Treatment Market by Region
        11.6.1    Market Overview
        11.6.2    North America
        11.6.3    Europe 
        11.6.4    Asia Pacific
        11.6.5    Latin America
        11.6.6    Middle East and Africa
12    North America Traveller’s Diarrhoea Treatment Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Traveller’s Diarrhoea Treatment Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Traveller’s Diarrhoea Treatment Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Traveller’s Diarrhoea Treatment Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Traveller’s Diarrhoea Treatment Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    Bausch Health Companies Inc.
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    COSMO Pharmaceuticals
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Immuron Ltd.
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Sanofi SA
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    Bayer AG
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Merck & Co., Inc
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Johnson & Johnson Services, Inc.
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Novartis AG
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    Basilea Pharmaceutica Ltd
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    Eli Lilly and Company
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
24    Traveller’s Diarrhoea Treatment - Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The global traveller’s diarrhoea treatment market size is expected to grow at a CAGR of 6% during the forecast period of 2024-2032.

The major drivers of the market include booming tourism business, rising awareness about the disease, rising demand from the developing regions, and the huge number of market players.

The key trends guiding the growth of the market include the availability of over-the-counter medications.

The major regions in the market include North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The drug types in the market include oral rehydration therapy (ORS), antidiarrhoeal agents, and vaccine/prophylactics, among others.

The pathogens in the market include bacteria, viruses, and protozoa, among others.

The age groups can be categorised into adult and children.

The routes of administration include oral and parenteral routes.

The distribution channels in the market include hospital pharmacies, retail pharmacies, and online pharmacies, among others.

The key players in the market include Bausch Health Companies Inc., COSMO Pharmaceuticals, Immuron Ltd., Sanofi SA, Bayer AG, Merck & Co., Inc, Johnson & Johnson Services, Inc., Novartis AG, Basilea Pharmaceutica Ltd, and Eli Lilly and Company.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER